Cell Biotech Co. Ltd (049960) — Strategic Asset Allocation Index
Cell Biotech Co. Ltd (049960) has a Strategic Asset Allocation Index of 24.2% as of March 2025. Strategic assets (PP&E of ₩29.77 Billion plus long-term investments of ₩-) total ₩29.77 Billion, measured against net assets of ₩123.28 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Cell Biotech Co. Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Cell Biotech Co. Ltd Strategic Asset Allocation Index (2011–2024)
This chart shows how Cell Biotech Co. Ltd's Strategic Asset Allocation Index has evolved across 14 annual periods from 2011 to 2024. As of March 2025, the index stands at 24.2%, representing strategic assets of ₩29.77 Billion against net assets of ₩123.28 Billion KRW. See 049960 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Cell Biotech Co. Ltd (2011–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Cell Biotech Co. Ltd from 2011 to 2024, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Cell Biotech Co. Ltd (049960) total market value.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 24.5% | ₩30.46 Billion | ₩30.46 Billion | ₩- | ₩124.17 Billion | ▼ -4.9 pp |
| 2023 | 29.4% | ₩32.94 Billion | ₩32.94 Billion | ₩- | ₩111.89 Billion | ▼ -1.7 pp |
| 2022 | 31.1% | ₩33.64 Billion | ₩33.64 Billion | ₩- | ₩108.09 Billion | ▼ -0.8 pp |
| 2021 | 31.9% | ₩34.06 Billion | ₩34.06 Billion | ₩- | ₩106.69 Billion | ▼ -4.7 pp |
| 2020 | 36.6% | ₩36.60 Billion | ₩36.60 Billion | ₩- | ₩99.98 Billion | ▲ +1.8 pp |
| 2019 | 34.8% | ₩36.07 Billion | ₩36.07 Billion | ₩- | ₩103.60 Billion | ▲ +7.7 pp |
| 2018 | 27.1% | ₩28.65 Billion | ₩28.65 Billion | ₩2.00 Million | ₩105.62 Billion | ▲ +1.1 pp |
| 2017 | 26.0% | ₩23.48 Billion | ₩23.18 Billion | ₩294.77 Million | ₩90.20 Billion | ▲ +2.5 pp |
| 2016 | 23.5% | ₩19.80 Billion | ₩19.52 Billion | ₩271.59 Million | ₩84.15 Billion | ▼ -4.9 pp |
| 2015 | 28.5% | ₩19.57 Billion | ₩18.78 Billion | ₩792.04 Million | ₩68.76 Billion | ▼ -5.5 pp |
| 2014 | 33.9% | ₩17.76 Billion | ₩16.77 Billion | ₩994.06 Million | ₩52.36 Billion | ▼ -6.3 pp |
| 2013 | 40.2% | ₩17.32 Billion | ₩16.46 Billion | ₩864.00 Million | ₩43.05 Billion | ▲ +6.5 pp |
| 2012 | 33.7% | ₩12.28 Billion | ₩10.94 Billion | ₩1.34 Billion | ₩36.42 Billion | ▲ +7.5 pp |
| 2011 | 26.3% | ₩8.34 Billion | ₩8.34 Billion | ₩- | ₩31.77 Billion | — |